Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease

Published:2021-08-26 Issue:9 Volume:7 Page:2591-2595
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

MacDonald Elizabeth A.¹,Frey Gary,Namchuk Mark N.^ORCID,Harrison Stephen C.¹²,Hinshaw Stephen M.^ORCID,Windsor Ian W.¹³^ORCID

Affiliation:

1. Laboratory of Molecular Medicine, Boston Children’s Hospital, Boston, Massachusetts 02115, United States

2. Howard Hughes Medical Institute, Boston, Massachusetts 02115, United States

3. Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts 02139, United States

Funder

Howard Hughes Medical Institute

Nancy Lurie Marks Family Foundation

National Institute of General Medical Sciences

Massachusetts Consortium for Pathogen Readiness

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.1c00237

Reference27 articles.

1. Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs

2. From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design

3. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors

4. Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188

5. Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries;Antimicrobial Agents and Chemotherapy;2024-08-28

2. Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus Agents;Biomolecules;2024-07-04

3. Structure-Guided Design of Potent Coronavirus Inhibitors with a 2-Pyrrolidone Scaffold: Biochemical, Crystallographic, and Virological Studies;Journal of Medicinal Chemistry;2024-07-02

4. Computational evaluation and benchmark study of 342 crystallographic holo-structures of SARS-CoV-2 Mpro enzyme;Scientific Reports;2024-06-20

5. High-Resolution Substrate Specificity Profiling of SARS-CoV-2 M^pro; Comparison to SARS-CoV M^pro;ACS Chemical Biology;2024-06-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3